L-DOPA REVERSES THE ELEVATED DENSITY OF D-2 DOPAMINE-RECEPTORS IN PARKINSONS DISEASED STRIATUM

被引：91

作者：

GUTTMAN, M

SEEMAN, P

机构：

[1] UNIV TORONTO, DEPT PHARMACOL, MED SCI BLDG, TORONTO M5S 1A8, ONTARIO, CANADA

[2] UNIV TORONTO, DEPT MED, TORONTO M5S 1A8, ONTARIO, CANADA

来源：

JOURNAL OF NEURAL TRANSMISSION | 1985年 / 64卷 / 02期

关键词：

D O I：

10.1007/BF01245971

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：93 / 103

页数：11

相关论文

共 27 条

[1] BIRKMAYER W, 1983, PARKINSONS DISEASE, P32
[2] [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY
BOKOBZA, B
RUBERG, M
SCATTON, B
JAVOYAGID, F
AGID, Y
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) : 167 - 175
[3] L-DOPA REVERSAL OF HYPER-DOPAMINERGIC BEHAVIOR
EZRINWATERS, C
SEEMAN, P
[J]. LIFE SCIENCES, 1978, 22 (12) : 1027 - 1032
[4] FRIEDHOFF AJ, 1977, RES COMMUN CHEM PATH, V16, P411
[5] CHRONIC L-DOPA TREATMENT OF RATS AND MICE DOES NOT CHANGE THE SENSITIVITY OF POST-SYNAPTIC DOPAMINE-RECEPTORS
JACKSON, DM
JENKINS, OF
MALOR, R
CHRISTIE, MJ
GREGORY, P
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1983, 324 (04) : 271 - 274
[6] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE
LEE, T
SEEMAN, P
RAJPUT, A
FARLEY, IJ
HORNYKIEWICZ, O
[J]. NATURE, 1978, 273 (5657) : 59 - 61
[7] DOPAMINE AGONISTS REVERSE THE ELEVATED H-3-NEUROLEPTIC BINDING IN NEUROLEPTIC-PRETREATED RATS
LIST, SJ
SEEMAN, P
[J]. LIFE SCIENCES, 1979, 24 (16) : 1447 - 1452
[8] Lonnberg P., 1980, PARKINSONS DISEASE C, P93
[9] OLSEN RW, 1980, LIFE SCI, V27, P801
[10] BEHAVIORAL AND BIOCHEMICAL-CHANGES FOLLOWING CHRONIC ADMINISTRATION OF L-DOPA TO RATS
PYCOCK, C
DAWBARN, D
OSHAUGHNESSY, C
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 79 (3-4) : 201 - 215